Veru Inc (VERU)

[Alleyba1]

AD-2,

Here is what I found yesterday:

Veru: The Signs Seem To Point To An EUA For Sabizabulin
Jul. 13, 2022 12:04 PM ETVeru Inc. (VERU)4 Comments7 Likes
Edmund Ingham profile picture
Edmund Ingham
Marketplace
Summary
Veru ought to find out very soon whether its lead asset, Sabizabulin, has been awarded an Emergency Use Authorization to treat hospitalized COVID patients.
The company's share price leapt >$20 when its COVID study data was published, showing a clinically and statistically meaningful 55% relative reduction in deaths.
There ought to be a blockbuster sales opportunity in play based on high unmet need, and that suggests Veru stock is still significantly undervalued.
The ex-COVID pipeline also offers hope for peak sales >$500m, while the Sexual Health Division revenues >$60m in FY21 ought to grow higher thanks to newly approved Entadfi in BPH.
As such, we can make a bull case for Veru stock - with the caveat that the market pushed shares as low as $2.5 when the Sabizabulin/COVID opportunity looked remote.
Looking for option income ideas that focus on capital preservation? I offer this and much more at my exclusive investing ideas service, Haggerston BioHealth. Learn More »
Blue vintage ringing alarm clock with bright yellow lightings